Comunicati Stampa
Scienza e Tecnologia
Scienza e Tecnologia
XNK Therapeutics to present at ABGSC Private Companies Seminar on December 6
For more information, please contact: For more information, please contact: Johan Liwing, CEO, XNK TherapeuticsTel: +46 706 70 36 75 E-mail:johan.liwing@xnktherapeutics.com This information was brought to you by Cisionhttp://news.cision.com https://news.cision.com/xnk-therapeutics-ab/r/xnk-therapeutics-to-present-at-abgsc-private-companies-seminar-on-december-6,c3463308 The following files are available for download:
STOCKHOLM,
(informazione.news - comunicati stampa - scienza e tecnologia)
Johan Liwing, CEO, XNK Therapeutics
Tel: +46 706 70 36 75
E-mail: johan.liwing@xnktherapeutics.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/xnk-therapeutics-ab/r/xnk-therapeutics-to-present-at-abgsc-private-companies-seminar-on-december-6,c3463308
The following files are available for download:
Ufficio Stampa
Allegati
Non disponibili